Medical News on Cancer
Blocking Pathway To T-Cell Acute Lymphoblastic Leukemia-Initiating Cell Regeneration
Jul 04, 2012
Research suggests that patients with leukemia sometimes relapse because standard chemotherapy fails to kill the self-renewing leukemia initiating cells, often referred to as cancer stem cells. In such cancers, the cells lie dormant for a time, only to later begin cloning, resulting in a return and metastasis of the disease... Read More
New Treatment For Breast Cancer Patients Cuts Radiotherapy Time In Half
Jul 03, 2012
Several breast cancer patients could be treated in half the time after research shows that accelerated whole breast irradiation after lumpectomy is an effective treatment for ductal carcinoma in situ (DCIS). The study is published in the International Journal of Radiation Oncology-Biology-Physics. DCIS is one of the most common forms of early stage and non-invasive forms of breast cancer... Read More
Effects Of Refusing Blood Transfusions After Cardiac Surgery
Jul 03, 2012
Although Jehovah's Witness patients do not believe in blood transfusions, their risk of surgical complications or death after heart surgery is not greater than patients who receive blood transfusions, say researchers. The study, conducted by Gregory Pattakos, M.D., M.S., of the Cleveland Clinic, Ohio, and his team, is published in Archives of Internal Medicine... Read More
Link Between Myelodysplastic Syndromes (MDS) And Abnormal Stem Cells
Jul 03, 2012
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that abnormal bone marrow stem cells drive the development of myelodysplastic syndromes (MDS), serious blood diseases that are common among the elderly and that can progress to acute leukemia. The findings could lead to targeted therapies against MDS and prevent MDS-related cancers... Read More
Men With Prostate Cancer Have Treatment Regret 52 Percent Higher If They Also Have Heart Disease
Jul 03, 2012
Prostate cancer patients with cardiovascular disease were 52 per cent more likely to regret their treatment choices than men without problems with their heart or veins, according to a study published in the July issue of the urology journal BJUI International... Read More
Gene Therapy Drugs Topically Delivered Via Commercial Moisturizers For Skin Disease Treatment
Jul 03, 2012
"Getting under your skin" takes on a brave new meaning thanks to Northwestern University research that could transform gene regulation... Read More
News From The Journal Of Clinical Investigation: July 2, 2012
Jul 03, 2012
CARDIOVASCULAR DISEASE Gene variant reduces cholesterol by two mechanisms High levels of low-density lipoprotein (LDL) cholesterol increases the risk for coronary heart disease. A variant in the human gene encoding the protein sortilin is associated with reduced plasma LDL levels and a decreased risk of heart attack... Read More
Discovery Of Lung Cancer Drug Resistance Secrets May Lead To New, More Powerful Precision Medicines That Thwart Resistance To Tarceva
Jul 03, 2012
People with lung cancer who are treated with the drug Tarceva face a daunting uncertainty: although their tumors may initially shrink, it's not a question of whether their cancer will return - it's a question of when. And for far too many, it happens far too soon... Read More
Link Between Caffeinated Coffee Consumption And Reduced Risk Of Most Common Form Of Skin Cancer
Jul 03, 2012
Increasing the number of cups of caffeinated coffee you drink could lower your risk of developing the most common form of skin cancer, basal cell carcinoma, according to a study published in Cancer Research, a journal of the American Association for Cancer Research... Read More
Thapsigargin For Cancer: GenSpera G-202 Data In Journal
Jul 03, 2012
GenSpera, Inc. (OTCBB:GNSZ) has announced that a study titled, "Engineering the Plant Product Thapsigargin into a PSMA-Activated Tumor Endothelial Cell Prodrug for Cancer Therapy," was published in the journal, Science Translational Medicine... Read More
Previous Page Next Page